کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4209777 | 1280496 | 2007 | 5 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Impact of lung transplantation on site of death in cystic fibrosis Impact of lung transplantation on site of death in cystic fibrosis](/preview/png/4209777.png)
BackgroundCystic fibrosis (CF) remains a lethal condition where a palliative approach is often taken at the end of life. We wanted to evaluate how lung transplantation impacts end of life care in adult CF patients.MethodsData were abstracted using a standardized data collection instrument from all outpatient and inpatient records of adult CF patients with an FEV1 ≤ 30% or prior lung transplantation followed at our Center. Comparisons were made between those who were listed/received lung transplant and those who were not listed.ResultsA total of 41 patients met the entry criteria. Of these, 63% (n = 26) were referred for lung transplant evaluation and 39% (n = 16) had undergone lung transplantation. Of these 41, 59% (n = 24) are deceased. The majority of deceased patients expired in an acute care hospital (63%, n = 15). There was no difference in site of death between the two groups (hospital versus home). However, listed/transplanted patients were more likely to die in an intensive care unit setting compared to patients not listed/transplanted (p = .013).ConclusionsMost of our CF patients' deaths occurred in an acute care hospital. Lung transplant significantly alters site of death and shifts it from medical floors to the intensive care unit.
Journal: Journal of Cystic Fibrosis - Volume 6, Issue 6, 30 November 2007, Pages 391–395